Ajanta Pharma

Ajanta Pharma Limited
Company type	Public
Traded as	BSE: 532331; NSE: AJANTPHARM;
Industry	Pharmaceuticals; Drugs; Healthcare;
Founded	1973
Headquarters	Mumbai, Maharashtra, India
Key people	Yogesh Agrawal (Managing Director); Rajesh Agrawal (Joint Managing Director);
Products	Branded Generic Formulations / Medicines
Revenue	₹4,648 crore (US$550 million) (2025)
Operating income	₹1,260 crore (US$150 million) (2025)
Net income	₹920 crore (US$110 million) (2025)
Number of employees	9,628 (March 2025)
Subsidiaries	Ajanta Pharma (Mauritius) Ltd.; Ajanta Pharma Philippines Inc.; Ajanta Pharma USA Inc.; Ajanta Pharma Nigeria Ltd.;
Website	www.ajantapharma.com
	Footnotes / references; Financials as of 31 March 2025.

Ajanta Pharma Limited, also known by the acronym APL, is an Indian multinational pharmaceutical company. It has a presence in India, the United States, and about 30 other countries in Africa, South East Asia, West Asia, and CIS. It was established in 1973.